The Thoroughbred Research and Education Foundation (TERF) is pleased to announce the awarding of $52,389 in research grants to the Equine Foundation. With a vision and mission to improve the lives of Thoroughbred Horses, TERF primarily aims to assist students in pursuing education in equine industry careers and to fund research efforts aimed at improving lives. of Thoroughbred racehorses.
* TERF awarded $20,000 to support the work of Dr. Alexandra Carlson at the University of Tennessee for research involving in vitro analysis on optimizing stem cell therapy for the treatment of osteoarthritis by using equine synovial fluid-derived mesenchymal stem cells using a soluble epoxide hydrolase inhibitor.
* Drew Koch at Northern California State University was awarded $19,986 for research involving dual licensing of mesenchymal stem cells to enhance tendon healing.
* Dr. Lauren Smanik at Colorado State University has been awarded $12,403 for the development of an experimental model of equine palmarthropathy (POD) that will allow researchers to study the progression of the disease. disease in a controlled manner.
The TERF Board of Directors meticulously selects grant recipients in a competitive grant process. TERF grants reflect the values set forth by founders Herb and Ellen Moelis. The current TERF Board of Directors includes co-chairs Kathleen Anderson DVM and James Orsini DVM, Margaret H. Duprey, Gretchen and Roy Jackson, Ellen Moelis, Wendy Moon, Anita Motion, Scott Palmer VMD, Josh Pons, Lucy Zungailia , Katelyn Jackson and Lynn Cassimeris , Ph.
To learn more about the Thoroughbred Research and Education Foundation and/or make tax-deductible donations to support TERF’s mission and programs, please visit www.terfusa.org.
This press release has not been edited by BloodHorse. If you have any questions, please contact the organization that produced the release.
